AstraZeneca agrees to divest Viela shareholding for upto $780mn
STOCKHOLM: AstraZeneca Plc has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio Inc. as part of the proposed acquisition of Viela by Horizon Therapeutics plc, a news release said. AstraZeneca is anticipating to receive…